The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
RNA-binding proteins with prion-like domains in health and disease
Open accessAbstract
Approximately 70 human RNA-binding proteins (RBPs) contain a prion-like domain (PrLD). PrLDs are low-complexity domains that possess a similar amino acid composition to prion domains in yeast, which enable several proteins, including Sup35 and Rnq1, to form infectious conformers, termed prions. In humans, PrLDs contribute to RBP function and enable RBPs to undergo liquid–liquid phase transitions that underlie the biogenesis of various membraneless organelles. However, this activity appears to render RBPs prone to misfolding and aggregation connected to neurodegenerative disease. Indeed, numerous RBPs with PrLDs, including TDP-43 (transactivation response element DNA-binding protein 43), FUS (fused in sarcoma), TAF15 (TATA-binding protein-associated factor 15), EWSR1 (Ewing sarcoma breakpoint region 1), and heterogeneous nuclear ribonucleoproteins A1 and A2 (hnRNPA1 and hnRNPA2), have now been connected via pathology and genetics to the etiology of several neurodegenerative diseases, including amyotrophic lateral sclerosis, frontotemporal dementia, and multisystem proteinopathy. Here, we review the physiological and pathological roles of the most prominent RBPs with PrLDs. We also highlight the potential of protein disaggregases, including Hsp104, as a therapeutic strategy to combat the aberrant phase transitions of RBPs with PrLDs that likely underpin neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–246 of 246
Whole-exome sequencing identifies a missense mutation in hnRNPA1 in a family with flail arm ALS
Liu, Q., Shu, S., Wang, R. R., Liu, F., Cui, B., Guo, X. N., Lu, C. X., Li, X. G., Liu, M. S., Peng, B., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003256 · Cited by 83
FUS and TDP43 genetic variability in FTD and CBS
Huey, E. D., Ferrari, R., Moreno, J. H., Jensen, C., Morris, C. M., Potocnik, F., Kalaria, R. N., Tierney, M., Wassermann, E. M., Hardy, J., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.004 · Cited by 82
Fecto, F., & Siddique, T. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9637-9 · Cited by 80
Lorenzetti, D., Bohlega, S., & Zoghbi, H. Y. (1997) · Neurology · doi:10.1212/wnl.49.4.1009 · Cited by 79
ALS and FTD: an epigenetic perspective
Belzil, V., Katzman, R. B., & Petrucelli, L. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1587-4 · Cited by 79
No evidence for cognitive dysfunction or depression in patients with mild restless legs syndrome
Driver‐Dunckley, E. D., Connor, D. J., Hentz, J., Sabbagh, M., Silverberg, N. B., Hernández‐Davó, J. L., Vedders, L. J., Evidente, V. G. H., Shill, H. A., Caviness, J. N., et al. (2009) · Movement Disorders · doi:10.1002/mds.22701 · Cited by 76
Torrente, M. P., & Shorter, J. (2013) · Prion · doi:10.4161/pri.27531 · Cited by 76
Self-citationVashist, S., Cushman-Nick, M., & Shorter, J. (2010) · Biochemistry and Cell Biology · doi:10.1139/o09-121 · Cited by 76
Self-citationNuclear Pre-mRNA Decapping and 5′ Degradation in Yeast Require the Lsm2-8p Complex
Kufel, J., Bousquet‐Antonelli, C., Beggs, J. D., & Tollervey, D. W. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9646-9657.2004 · Cited by 76
Engineering enhanced protein disaggregases for neurodegenerative disease
Jackrel, M. E., & Shorter, J. (2015) · Prion · doi:10.1080/19336896.2015.1020277 · Cited by 75
Self-citationHay, D. C., Kemp, G. D., Dargemont, C., & Hay, R. T. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3482-3490.2001 · Cited by 75
Chiò, A., Calvo, A., Moglia, C., Restagno, G., Ossola, I., Brunetti, M., Montuschi, A., Cistaro, A., Ticca, A., Traynor, B. J., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.173 · Cited by 74
Moreno, F., Rabinovici, G. D., Karydas, A., Miller, Z., Hsu, S. C., Legati, A., Fong, J. C., Schonhaut, D. R., Esselmann, H., Watson, C., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0190-6 · Cited by 72
The Sam68 nuclear body is composed of two RNase-sensitive substructures joined by the adaptor HNRNPL
Mannen, T., Yamashita, S., Tomita, K., Goshima, N., & Hirose, T. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201601024 · Cited by 69
Bose, S., & Cho, J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.004 · Cited by 65
Characterization of the Asian myopathy patients with VCP mutations
Shi, Z., Hayashi, Y. K., Mitsuhashi, S., Goto, K., Kaneda, D., Choi, Y., Toyoda, C., Hieda, S., Kamiyama, T., Sato, H., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03575.x · Cited by 64
Targeted Exon Capture and Sequencing in Sporadic Amyotrophic Lateral Sclerosis
Couthouis, J., Raphael, A. R., Daneshjou, R., & Gitler, A. D. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004704 · Cited by 62
Sbp1p Affects Translational Repression and Decapping in Saccharomyces cerevisiae
Segal, S. P., Dunckley, T. L., & Parker, R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01913-05 · Cited by 62
Liquids, Fibers, and Gels: The Many Phases of Neurodegeneration
Elbaum‐Garfinkle, S., & Brangwynne, C. P. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.11.014 · Cited by 61
Extensive molecular genetic survey of Taiwanese patients with amyotrophic lateral sclerosis
Soong, B., Lin, K., Guo, Y.-C., Lin, C. K., Tsai, P., Liao, Y., Lu, Y., Wang, S., Tsai, C., & Lee, Y. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.008 · Cited by 60
Abel, O., Shatunov, A., Jones, A. R., Andersen, P. M., Powell, J. F., & Al‐Chalabi, A. (2013) · JMIR mhealth and uhealth · doi:10.2196/mhealth.2706 · Cited by 60
Clinical phenotypes and radiological findings in frontotemporal dementia related to TARDBP mutations
Floris, G., Borghero, G., Cannas, A., Stefano, F. D., Murru, M. R., Corongiu, D., Cuccu, S., Tranquilli, S., Cherchi, M. V., Serra, A., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7575-5 · Cited by 59
Emergence and natural selection of drug-resistant prions
Shorter, J. (2010) · Molecular BioSystems · doi:10.1039/c004550k · Cited by 59
Self-citationMarko, M., Vlassis, A., Guialis, A., & Leichter, M. (2012) · Gene · doi:10.1016/j.gene.2012.06.088 · Cited by 56
Neumann, M., Igaz, L. M., Kwong, L. K., Nakashima‐Yasuda, H., Kolb, S. J., Dreyfuss, G., Kretzschmar, H. A., Trojanowski, J. Q., & Lee, V. M. ‐. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0221-x · Cited by 56
Engineering therapeutic protein disaggregases
Shorter, J. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-10-0693 · Cited by 53
Self-citationCampillos, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg435 · Cited by 50
Management and therapeutic perspectives in amyotrophic lateral sclerosis
Mathis, S., Couratier, P., Julian, A., Vallat, J., Corcia, P., & Masson, G. L. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1227705 · Cited by 50
Beer and Bread to Brains and Beyond: Can Yeast Cells Teach Us about Neurodegenerative Disease?
Gitler, A. D. (2007) · Neurosignals · doi:10.1159/000109759 · Cited by 49
Prion proteostasis: Hsp104 meets its supporting cast
Sweeny, E. A., & Shorter, J. (2008) · Prion · doi:10.4161/pri.2.4.7952 · Cited by 45
Self-citationHsp104 Drives “Protein-Only” Positive Selection of Sup35 Prion Strains Encoding Strong [PSI]
DeSantis, M. E., & Shorter, J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.09.013 · Cited by 44
Self-citationThe Frontotemporal Syndromes of ALS. Clinicopathological Correlates
Strong, M. J., & Yang, W. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9609-0 · Cited by 41
The balbiani body and the concept of physiological amyloids
Böke, E., & Mitchison, T. J. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1241605 · Cited by 41
Reversing deleterious protein aggregation with re-engineered protein disaggregases
Jackrel, M. E., & Shorter, J. (2014) · Cell Cycle · doi:10.4161/cc.28709 · Cited by 38
Self-citationNovel TARDBP mutations in Nordic ALS patients
Chiang, H., Andersen, P. M., Tysnes, O., Gredal, O., Christensen, P., & Graff, C. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.24 · Cited by 36
Disparate Mutations Confer Therapeutic Gain of Hsp104 Function
Jackrel, M. E., Yee, K., Tariq, A., Chen, A. I., & Shorter, J. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00765 · Cited by 35
Self-citationChung, P. Y. J., Beyens, G., de Freitas, F., Boonen, S., Geusens, P., Vanhoenacker, F. M. H. M., Verbruggen, L., Offel, J. V., Goemaere, S., Zmierczak, H., et al. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.03.021 · Cited by 33
Shorter, J. (2016) · Nature Chemistry · doi:10.1038/nchem.2534 · Cited by 33
Self-citationEffects of Mutations on the Aggregation Propensity of the Human Prion-Like Protein hnRNPA2B1
Paul, K. R., Molliex, A., Cascarina, S., Boncella, A. E., Taylor, J., & Ross, E. D. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00652-16 · Cited by 33
Pinkus, J. L., Amato, A. A., Taylor, J. P., & Greenberg, S. A. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.04.012 · Cited by 28
Lu, H.-P., Gan, S., Chen, S., Li, H., Liu, Z., Wang, N., Wang, N., & Wu, Z. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.015 · Cited by 23
Jean-Philippe, J., Paz, S., Lu, M. L., & Caputi, M. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.02.002 · Cited by 21
Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies
Li, Y., Tan, M., Yu, J., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9507-5 · Cited by 21
Towards a Better Treatment Option for Parkinson’s Disease: A Review of Adult Neurogenesis
Farzanehfar, P. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2053-3 · Cited by 20
The promises of neurodegenerative disease modeling
Lepesant, J. (2015) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2015.06.018 · Cited by 7
Fleeting Amyloid-like Forms of Rim4 Ensure Meiotic Fidelity
Ford, A. F., & Shorter, J. (2015) · Cell · doi:10.1016/j.cell.2015.09.049 · Cited by 7
Self-citation
Cited by
The molecular language of membraneless organelles
Gomes, E., & Shorter, J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.001192 · Cited by 777
Self-citationMolecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., & Patel, B. K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00025 · Cited by 774
Murray, D. T., Kato, M., Lin, Y., Thurber, K. R., Hung, I., McKnight, S. L., & Tycko, R. (2017) · Cell · doi:10.1016/j.cell.2017.08.048 · Cited by 757
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Mejzini, R., Flynn, L. L., Pitout, I. L., Fletcher, S., Wilton, S. D., & Akkari, P. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01310 · Cited by 755
Phase separation of a yeast prion protein promotes cellular fitness
Franzmann, T. M., Jahnel, M., Pozniakovsky, A., Mahamid, J., Holehouse, A. S., Nüske, E., Richter, D., Baumeister, W., Grill, S. W., Pappu, R. V., et al. (2018) · Science · doi:10.1126/science.aao5654 · Cited by 737
Metadata
- Authors
- Harrison, A. F., & Shorter, J.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2017-04-07
- Volume
- 474
- Issue
- 8
- Pages
- 1417-1438
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2604909829
- Cited by
- 422
- References
- 246
- FWCI
- 28.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.